The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (The QoLiTax-Trial of the Arbeitsgemeinschaft Internistische Onkologie, AIO)

Authors :: Andreas Hübner
Claudia Pauligk
Ralf Hofheinz
Salah-Eddin Al-Batran
Michael Koenigsmann
Manfred Welslau
Rosemarie Kuhl
Christiane Windemuth-Kieselbach
Martin Burmester
Jochen Eggert
Jörg Wiegand
Axel Hinke
Felix Tauchert
Wael Hozaeel
Source :: Journal of Clinical Oncology. 32:9621-9621
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: 9621 Background: Docetaxel is a widely used cytotoxic agent. It causes a number of side effects, most frequently leukopenia and neutropenia, alopecia, nausea, diarrhea, and fatigue. This study eval...

Full Text Access

Tools